
Dimeji Lanade, MD
@lanademd
Heme/Onc Fellow @LevineCancer🤓 | Former Medical Director💼 | @UTHSC_medicine alum🍊| Health Equity, Advocacy, Leadership. Tweets = my own opinions. 🇳🇬
ID: 1270143616242024450
09-06-2020 00:00:30
60 Tweet
46 Followers
96 Following



NC team from Levine Cancer (including 2 of our fellows!) representing at our 2025 ASCO Advocacy summit. Let’s ensure that our pts have access to high quality cancer care. #ASCOadvocacysummit #ASCOact Atrium Health


NC ASCO delegation is ready to go… representing Atrium Health Duke Cancer ECU Wake Forest Baptist - Comprehensive Cancer Center on the Hill. Pts first! ✅ Cont to support #cancer research funding. ✅ Make prior auth process more equitable. ✅ End cancer drug shortages #ASCOAdvocacySummit #advocacy



Our NC team is ready to go! Our @asco delegation from Atrium Health Duke Cancer ECU Wake Forest Baptist - Comprehensive Cancer Center on the Hill Our goals: ✅ Cont to support #cancer research funding. ✅ Make prior auth process more equitable. ✅ End cancer drug shortages #ASCOAdvocacySummit #advocacy



Kudos to Dimeji Lanade, MD for his 1st testimony w @asco at AMA HOD to urge AMA to support pt’s rights to participate in health care decisions via informed choices. Dr Lanade is one of our Levine Cancer hem/onc fellows & is passionate about #advocacy. LCI Fellows



Kudos to Dimeji Lanade, MD for His First ASCO Testimony Urging AMA Support for Patient's Rights - Ashley Love Sumrall, MD, FACP, FASCO AMA oncodaily.com/url/310060 #OncoDaily #Oncology #Cancer #Health #Medicine


At Levine Cancer we are serious about patient advocacy as well as mentoring our trainees in this space. It was terrific to welcome our 2nd oncology fellow from LCI Fellows to #AMAmtg 👉🏻 Dimeji Lanade, MD THIS is how to improve medicine. ⭐️AMA #AMA25 ASCO #advocacy



Despite the flight delays😮💨, made it to ESMO GI, great day 1🙌🏿 ESMO - Eur. Oncology #ESMOGI2025


Thanks Dr. De Dosso for your career insight during this great mentor session! ESMO - Eur. Oncology


❓MSS tumors in lynch syndrome & better understanding response to immunotherapy 💫 MSI-H vs MSS Tumors in Lynch Syndrome —Are there patient and disease distinctions between the two? ✅ Our study suggested so! Thanks ESMO - Eur. Oncology #ESMOGI2025 #coloncancer #gioncology


MSS Tumors in Lynch Syndrome and Better Understanding Response to Immunotherapy - Dimeji Lanade, MD ESMO - Eur. Oncology oncodaily.com/blog/dimeji-la… #Immunotherapy #IO #ImmuneOnc #ESMOGI25 #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

